Achilles Therapeutics

NASDAQ: ACHL · Real-Time Price · USD
1.48
0.00 (0.00%)
At close: Mar 20, 2025, 3:59 PM

Achilles Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-69.94M -71.18M -61.1M
Depreciation & Amortization
4.71M 3.69M 3.29M
Stock-Based Compensation
6.36M 7.02M 6.32M
Other Working Capital
10.41M -7.86M -5.36M
Other Non-Cash Items
7.03K 6.88M -18K
Deferred Income Tax
n/a n/a 159K
Change in Working Capital
10.41M -5.96M -7.93M
Operating Cash Flow
-48.45M -59.53M -59.28M
Capital Expenditures
-1.1M -7.51M -7.63M
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a -7.51M -7.63M
Investing Cash Flow
-1.1M -7.51M -7.63M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 0.62 160.75M
Financial Cash Flow
9K 1K 160.75K
Net Cash Flow
-41.8M -92.98M 88.5M
Free Cash Flow
-49.55M -67.05M -66.92M